Showing results (181-190 of 541) with videos related to

Sort By:
Pageof 55
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1976
Factors influencing nonspecific binding of glucocorticoids in myocardial tissueA C Beardsley, M Okuda, A M Lefer
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Heparinase III exerts endothelial and cardioprotective effects in feline myocardial ischemia-reperfusion injuryR Hayward, T O Nossuli, A M Lefer
International Archives of Allergy and Applied Immunology|January 1, 1986
Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonistsH Darius, J B Smith, A M Lefer
The American Journal of Physiology|March 1, 1996
Novel recombinant serpin, LEX-032, attenuates myocardial reperfusion injury in catsJ A Delyani, T Murohara, A M Lefer
Shock (Augusta, Ga.)|October 1, 1995
Beneficial effects of LEX032, a novel recombinant serine protease inhibitor, in murine traumatic shockR Scalia, T W Gauthier, A M Lefer
Journal of Cardiovascular Pharmacology|September 1, 1983
Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitorS E Burke, G DiCola, A M Lefer
European Journal of Pharmacology|June 21, 1990
Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shockA Karasawa, P A Taylor, A M Lefer
Critical Care Medicine|February 1, 1991
Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusionG Johnson, P S Tsao, A M Lefer
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1987
Additive beneficial effects of two inhibitors of vasoconstrictor mediators in acute myocardial ischemiaH Bitterman, D J Lefer, A M Lefer
Pageof 55